Development of a molecule-recognized promoter DNA sequence for inhibition of HER2 expression.
Suzuki
Tsukasa
T
Division of Cancer Genetics, Department of Advanced Medical Science, Nihon University School of Medicine, Ooyaguchi-kamimachi, Tokyo, Japan.
Asami
Yukihiro
Y
Takahashi
Teruyuki
T
Wang
Xiaofei
X
Watanabe
Takayoshi
T
Bando
Toshikazu
T
Sugiyama
Hiroshi
H
Fukuda
Noboru
N
Nagase
Hiroki
H
D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D001665:Binding Sites / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D020868:Gene Silencing / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D009757:Nylons / Q000138:chemical synthesis* / Q000494:pharmacology*; D011401:Promoter Regions, Genetic / Q000187:drug effects / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000235:genetics*; D050656:Transcription Factor AP-2 / Q000187:drug effects
D000970:Antineoplastic Agents; D009757:Nylons; D012333:RNA, Messenger; D018719:Erb-b2 Receptor Tyrosine Kinases; D050656:Transcription Factor AP-2; C508053:ERBB2 protein, human